Definitive Healthcare Corp. Class A (DH)

In the past six months, Definitive Healthcare Corp. (DH) stock has experienced a significant decline. The company reported its first-quarter 2026 financial results with a revenue decrease and a sharp net loss due to a non-cash goodwill impairment charge. Management cited continued weakness in the life sciences vertical, past sales execution challenges, macroeconomic pressure, and elevated churn as contributing factors. The company initiated a 2026 restructuring plan, reducing headcount. Analysts have lowered price targets for Definitive Healthcare.

The provided search results do not contain explicit information about the demand seasonality for Definitive Healthcare Corp.'s products and services. As a SaaS-based healthcare commercial intelligence platform, demand might be influenced by factors such as healthcare industry trends and budget cycles. The company's revenue is primarily derived from subscription fees, suggesting a relatively stable, recurring revenue model.

Definitive Healthcare Corp. (DH) is a leading provider of healthcare commercial intelligence, operating within the Professional, Scientific, and Technical Services sector. The company transforms data, analytics, and expertise into actionable insights for the healthcare ecosystem through its SaaS platform. This platform offers comprehensive information on healthcare organizations, clinicians, claims, consumers, and experts in the United States, helping clients with various functional areas. Definitive Healthcare derives substantially all of its revenue from subscription fees for access to its platform and support.

Definitive Healthcare is a global organization with offices in the U.S., Sweden, and India, but its platform primarily focuses on providing information on the healthcare ecosystem in the United States, and the company derives a majority of its revenue from the U.S. market. The company's headquarters are located in Framingham, Massachusetts, United States.

Definitive Healthcare positions itself as an industry leader in healthcare commercial intelligence, aiming to provide reliable, actionable, and differentiated insights. The company emphasizes its mission to connect with the people who make healthcare happen through real data and its commitment to corporate sustainability. However, significant goodwill impairment charges and reported revenue decline and customer churn could negatively impact investor perception and brand reputation.

Definitive Healthcare Corp. has a concentrated ownership structure, with institutional investors holding a significant majority of shares. Major institutional owners include Advent International Corp/ma, Goldman Sachs Group Inc, and BlackRock, Inc. The company's founder, Jason Krantz, also maintains a significant insider stake.